Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by AKAMPION
< Previous
1
2
Next >
selectION Announces Positive Results from Phase 1b Clinical Trial Evaluating si-544 in Patients with Atopic Dermatitis
April 29, 2024
From
AKAMPION
Via
GlobeNewswire
Transferring Biomedical Research to Patients Faster: ForTra gGmbH Announces Positive Funding Track Record
April 23, 2024
From
AKAMPION
Via
GlobeNewswire
BellaSeno Appoints Dr. Thomas Lingner as Chief Technology Officer and Inga Freyert as VP Quality and Regulatory Affairs
April 03, 2024
From
AKAMPION
Via
GlobeNewswire
MetrioPharm Establishes Scientific Advisory Board of Seasoned Immunology and Pediatric Experts
March 13, 2024
From
AKAMPION
Via
GlobeNewswire
BellaSeno’s 3D-printed Resorbable Scaffold Successfully Used in Critical-Size Large Segmental Radius Bone Defect at Hannover Medical School
March 05, 2024
From
AKAMPION
Via
GlobeNewswire
Omnix Medical Granted Fast-Track Designation by U.S. FDA for its Next-Generation Anti-Infective OMN6
February 20, 2024
From
AKAMPION
Via
GlobeNewswire
Thermosome Announces Further Dose Escalation in Phase I Trial with Lead Program THE001
February 06, 2024
From
AKAMPION
Via
GlobeNewswire
MetrioPharm Publishes First Trial Data Showing Effects of Host-Directed Therapy in COVID-19
January 31, 2024
From
AKAMPION
Via
GlobeNewswire
New investigator-initiated clinical trials of BellaSeno´s resorbable tissue regeneration scaffolds to be conducted in Europe
January 31, 2024
From
AKAMPION
Via
GlobeNewswire
selectION, Inc. to Present Update on Clinical Progress at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA, on January 11, 2024
January 05, 2024
From
AKAMPION
Via
GlobeNewswire
1ST Biotherapeutics, Inc. Announces First Patient Dosed in Phase I/II Study of HPK1 Inhibitor FB849 in Patients with Advanced Solid Tumors
December 14, 2023
From
AKAMPION
Via
GlobeNewswire
ImmunOs Therapeutics Presents Details of Novel Bispecific Anti-Tumor Molecules at ESMO Immuno-Oncology Congress 2023
December 11, 2023
From
AKAMPION
Via
GlobeNewswire
Thermosome Appoints Dr. Frank Hermann, MD, as Chief Medical Officer and Adds Prof. Alessandro Gronchi, MD, to Clinical Advisory Board
December 05, 2023
From
AKAMPION
Via
GlobeNewswire
EBViously Presents Novel In-Vitro Data Demonstrating Potent Infection Prevention of its Vaccine Candidate EBV-001
December 04, 2023
From
AKAMPION
Via
GlobeNewswire
Ebenbuild to Receive Public Funding Under UBIC Consortium for Digital Lung Twin Project
November 28, 2023
From
AKAMPION
Via
GlobeNewswire
Omnix Medical Receives U.S. FDA Approval of a Phase II Trial of its Next-Generation Anti-Infective OMN6
November 20, 2023
From
AKAMPION
Via
GlobeNewswire
Dr. Hartmut Tintrup joins Cellbox Solutions GmbH as new CEO
November 01, 2023
From
AKAMPION
Via
GlobeNewswire
BellaSeno Presents Novel Production Workflow for Customized, 3D-Printed Bone Scaffolds
October 30, 2023
From
AKAMPION
Via
GlobeNewswire
ImmunOs Therapeutics Presents Overview of Phase 1a/b Trial of Lead Compound IOS-1002
October 24, 2023
From
AKAMPION
Via
GlobeNewswire
ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA
October 17, 2023
From
AKAMPION
Via
GlobeNewswire
Dopavision Reports Successful Completion of Enrollment for MyopiaX-1 Trial
September 26, 2023
From
AKAMPION
Via
GlobeNewswire
Cellbox Solutions Submits Device Master File (DMF) to the U.S. FDA
September 25, 2023
From
AKAMPION
Via
GlobeNewswire
1ST Biotherapeutics Announces Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate FB849 in Combination With KEYTRUDA® (pembrolizumab)
September 19, 2023
From
AKAMPION
Via
GlobeNewswire
Thermosome Establishes High-Profile Clinical Advisory Board
September 19, 2023
From
AKAMPION
Via
GlobeNewswire
ImmunOs Therapeutics Appoints Dr. Constanze Guenther as Senior Vice President, CMC and Technical Development
September 19, 2023
From
AKAMPION
Via
GlobeNewswire
BellaSeno Reports Positive One-Year Patient Follow-Up Data for Resorbable Breast and Pectus Excavatum Scaffolds
September 05, 2023
From
AKAMPION
Via
GlobeNewswire
TolerogenixX expands Phase II immune-tolerance trial and closes EUR 12 million Series A financing
July 06, 2023
From
AKAMPION
Via
GlobeNewswire
BellaSeno Granted Market Access in Europe for Custom-Made Bone and Pectus Excavatum Scaffolds
July 06, 2023
From
AKAMPION
Via
GlobeNewswire
Cellbox Solutions GmbH Awarded €2.5 Million Grant Combined with an Equity Component of up to €10 Million Under the European Innovation Council´s Accelerator Program
July 05, 2023
From
AKAMPION
Via
GlobeNewswire
Oliver Healthcare Packaging Strengthens Supply Chain, Adds In-Region Film & Foil Production
June 29, 2023
From
AKAMPION
Via
GlobeNewswire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.